Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
- 1
- Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University, BioMeditech and Tays Cancer Center, Tampere University Hospital, P.O. Box 553, 33101 Tampere, Finland
- 2
- Predictive Medicine and Data Analytics Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
- 1
- Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University and BioMeditech, P.O. Box 553, 33101 Tampere, Finland
- 2
- Tays Cancer Center, Tampere University Hospital, 33520 Tampere, Finland
- 3
- Predictive Medicine and Data Analytics Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
- 4
- Department of Biotechnology, Lady Doak College, Madurai 625002, India
- 5
- Faculty of Engineering and Natural Sciences, Tampere University, 33101 Tampere, Finland
- 6
- Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
- 7
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
- 8
- Computational Systems Biology Group, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
- 9
- Institute for Systems Biology, 1441N 34th Street, Seattle, WA 98103-8904, USA
Reference
- Viswanathan, A.; Musa, A.; Murugesan, A.; Vale, J.R.; Afonso, C.A.M.; Mani, S.K.; Yli-Harja, O.; Candeias, N.R.; Kandhavelu, M. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Viswanathan, A.; Musa, A.; Murugesan, A.; Vale, J.R.; Afonso, C.A.M.; Mani, S.K.; Yli-Harja, O.; Candeias, N.R.; Kandhavelu, M. Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. Cells 2020, 9, 2631. https://doi.org/10.3390/cells9122631
Viswanathan A, Musa A, Murugesan A, Vale JR, Afonso CAM, Mani SK, Yli-Harja O, Candeias NR, Kandhavelu M. Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. Cells. 2020; 9(12):2631. https://doi.org/10.3390/cells9122631
Chicago/Turabian StyleViswanathan, Anisha, Aliyu Musa, Akshaya Murugesan, João R. Vale, Carlos A. M. Afonso, Saravanan Konda Mani, Olli Yli-Harja, Nuno R. Candeias, and Meenakshisundaram Kandhavelu. 2020. "Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624" Cells 9, no. 12: 2631. https://doi.org/10.3390/cells9122631